NCT04306367
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +3 more
- Locations
-
- Lombardi Comprehensive Cancer Center, Georgetown University Washington D.C., District of Columbia, United States
Clinical trial condition
Cholangiocarcinoma
Explore clinical trials studying Cholangiocarcinoma. Study availability and eligibility vary by location and protocol.
269 public trials
77 recruiting studies
Cholangiocarcinoma trial results
NCT04028479
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adenocarcinoma, +249 more
- Locations
-
- Teton Cancer Institute Idaho Falls, Idaho, United States
- Oncology and Hematology of South Texas Laredo, Texas, United States
NCT03999593
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
- Locations
-
Not specified
NCT06570174
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +18 more
- Locations
-
- Department of Surgery, Yonsei University College of Medicine Seoul, South Korea
Completed
Study to Evaluate the Efficacy and Safety of TT-00420 (Tinengotinib) in Cholangiocarcinoma
NCT04919642
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +7 more
- Locations
-
- Providence Cancer Center Anchorage, Alaska, United States
- City of Hope Duarte, California, United States
- University of California, Los Angeles, School of Medicine Santa Monica, California, United States
- USO Oncology Network- Rocky Mountain Cancer Centers Denver, Colorado, United States
Completed
FLUOPANC-trial - Fluorescence-guided Surgery of Pancreatic and Bileduct Tumors Using cRGD-ZW800-1
NCT05518071
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
- Locations
-
- Leiden University Medical Center Leiden, Netherlands
NCT04256980
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +3 more
- Locations
-
- Zhongshan Hospital Affiliated to Fudan University Shanghai, Shanghai Municipality, China
NCT04742959
- Conditions
- Adenocarcinoma, Advanced Solid Tumor, Biliary Tract Diseases, +57 more
- Locations
-
- City of Hope Duarte, California, United States
- The University of Chicago Chicago, Illinois, United States
- Rutgers Cancer Institute New Brunswick, New Jersey, United States
- Gabrail Cancer Center Research Canton, Ohio, United States
Completed
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
NCT03329950
- Conditions
- Adenocarcinoma, Adnexal Diseases, Bile Duct Diseases, +120 more
- Locations
-
- HonorHealth Research Insititute Scottsdale, Arizona, United States
- Northside Hospital, Inc. Atlanta, Georgia, United States
- Georgia Cancer Center at Augusta University Augusta, Georgia, United States
- Oncology Hematology West, PC dba Nebraska Cancer Specialists Omaha, Nebraska, United States
NCT04059562
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +3 more
- Locations
-
- Klinik für Gastroenterologie, Hepatologie und Infektiologie Düsseldorf, North Rhine-Westphalia, Germany